Immersion Corporation IMMR
7.28
(0.01)
(0.14%)
as of 25 Sep
- Market cap
- $237.4M
- P/E
- 171×
Follow IMMR
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
177.46 | 40.87 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.14 | 0.12 | 0.12 | 0.12 | |
P/FCF ratio |
4.10 | 4.70 | 21.53 | 130.77 | |
P/Operating CF |
(5.75) | 2.40 | (6.65) | 3.11 | |
P/B ratio |
0.45 | 0.36 | 0.40 | 0.38 | |
Price to Tangible BV |
0.62 | 0.49 | 0.56 | 0.53 | |
EV/Sales |
0.10 | 0.05 | 0.10 | 0.09 | |
EV/EBITDA |
2.20 | 1.34 | 3.86 | 2.01 | |
EV/Operating CF |
2.13 | 1.56 | 7.31 | 10.11 | |
EV/FCF |
2.69 | 2.15 | 17.74 | 92.57 | |
Quick Ratio |
1.03 | 1.02 | 1.08 | 1.02 | |
Current Ratio |
2.14 | 2.30 | 1.83 | 1.88 | |
Net Debt/EBITDA |
8.82 | (6.02) | (2.52) | (1.27) | |
Debt/Assets |
10.50% | 6.75% | 9.66% | 8.90% | |
Debt/Equity |
0.22 | 0.13 | 0.25 | 0.21 | |
Asset Turnover |
1.42 | 1.61 | 1.31 | 1.32 | |
Operating CF/Net income |
(8.94) | 22.53 | 3.29 | 5.89 | |
Capex/Depreciation |
(0.34) | (0.40) | (0.35) | (0.41) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.05% | 27.33% | 14.49% | 12.34% | |
Intangible Assets out of Total Assets |
0.13 | 0.15 | 0.11 | 0.12 | |
Share Based Compensation of Revenue |
0.71% | 0.73% | 0.39% | 0.42% | |
Graham Net Nets |
0.77 | 0.94 | 0.64 | 0.60 | |
Graham Number |
4.02 | 7.63 | 0.00 | 0.00 | |
Earnings Yield |
0.56% | 2.45% | (15.53%) | (4.17%) | |
Free Cash Flow Yield |
24.39% | 21.28% | 4.64% | 0.76% | |
Revenue per Share |
8.88 | 8.22 | 15.74 | 19.80 | |
Operating CF per Share |
(1.31) | 2.55 | (1.02) | 2.15 | |
Capex per Share |
(0.11) | (0.13) | (0.11) | (0.13) | |
Free Cash Flow per Share |
(1.42) | 2.42 | (1.14) | 2.02 | |
Cash per Share |
6.32 | 5.49 | 5.40 | 5.68 | |
Shareholders Equity per Share |
16.87 | 17.27 | 17.06 | 17.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.87 | 17.27 | 17.06 | 17.48 | |
Free Cash Flow |
(47.12) | 79.43 | (37.49) | 66.32 | |
Working Capital |
431.52 | 381.80 | 459.41 | 438.53 | |
Capital Expenditures |
(3.53) | (4.41) | (3.73) | (4.31) | |
Net Current Asset Value |
193.39 | 190.22 | 142.66 | 131.00 | |
EV/EBIT |
5.10 | 3.55 | 32.86 | 4.33 | |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.01 | |
Net Profit Margin |
1.66% | 1.38% | (1.98%) | 1.84% | |
Price to Operating Income |
7.76 | 7.77 | 39.87 | 6.12 | |
| Other line items | |||||
Average Receivables |
173.00 | 109.74 | 388.06 | 299.36 | |
Average Payables |
223.80 | 142.22 | 311.44 | 322.23 | |
Average Inventory |
390.80 | 325.69 | 370.47 | 371.37 | |
Average Assets |
1,219.11 | 1,077.31 | 1,401.63 | 1,348.61 | |
Average Common Equity |
552.66 | 563.05 | 564.15 | 528.17 |
Columns are period end dates